Population pharmacokinetics of isavuconazole from phase 1 and phase 3 (SECURE) trials in adults and target attainment in patients with invasive infections due to Aspergillus and other filamentous fungi - Desai, A; Kovanda, L; Kowalski, D; Lu, Q; Townsend, R; Bonate, P L (Antimicrob Agents Chemother, 2016)